Latest Reports

Market Scope’s “2025 Ophthalmic Diagnostic Equipment Survey Report” provides a data-driven snapshot of how United States ophthalmologists and optometrists are evaluating, purchasing, and using diagnostic technologies in today’s evolving clinical environment.  

Based on a nationwide online survey of 480 verified providers, the report delivers direct insight into capital investment priorities, technology adoption, and the growing influence of digital tools, AI, and data integration across ophthalmic practices.  

This survey report examines how and why purchasing decisions are made, what features and services matter most, how diagnostic budgets are changing, and where practices see value in next-generation technologies. Coverage spans core diagnostic categories as well as fast-growing areas such as artificial intelligence, interoperability, digital applications, and telehealth—offering both a current-state assessment and a forward-looking view of the diagnostic landscape. 

Survey questions were developed by Market Scope in collaboration with sponsoring companies, ensuring the data addresses the most commercially and strategically relevant issues facing diagnostic equipment manufacturers.  

The “2025 Cataract Pharmaceuticals Market Report” provides a comprehensive, data-driven market analysis of the drugs used before, during, and after cataract surgery in the United States and Western Europe. The report examines current utilization patterns and provides five-year forecasts for revenue by product category. 

Coverage includes antibiotics, anti-inflammatory agents, mydriatics/cycloplegics, pain management drugs, and intracameral formulations, along with a detailed look at fixed combinations, branded products, generics, and compounded alternatives. The report also explores evolving surgical practices, the growing role of intracameral injections, reimbursement dynamics, and the competitive pipeline shaping the future of cataract pharmaceuticals.  

The “2025 Dry Eye Pharmaceuticals Market Report” provides a comprehensive analysis of the global market for dry eye therapeutics, examining the disease’s prevalence, diagnosis, and treatment landscape. The report provides in-depth coverage of artificial tears, anti-inflammatory drops, miticides, tear evaporation inhibitors, mucin secretagogues, and other prescription and over-the-counter products—with detailed forecasts of unit demand, sales revenue, and market performance by region through 2030. 

The report offers a data-driven assessment of the current dry eye marketplace and its growth potential, highlighting new product development, emerging drug-delivery methods, and the expanding pharmaceutical pipeline. Global and regional forecasts are presented for seven major regions, with coverage of competitive dynamics, regulatory differences, and therapeutic trends. Profiles are provided for 23 leading companies and their strategic positioning within the dry eye market. 

The new first-edition “2025 Dry Eye Device Market Report” delivers a comprehensive analysis of the global market for the devices and procedures used in the diagnosis and treatment of dry eye disease. The report examines the drivers behind device adoption, evaluates current and emerging technologies, and forecasts procedure volumes, unit demand, and market performance through 2030. 

Competitive dynamics are analyzed across key product categories, including thermal expression devices, light-based systems, punctum plugs, eyelid debridement, scleral lens and amniotic tissue procedures, and other technologies, with detailed profiles of leading manufacturers and their strategic positioning. 

Market Scope’s “2025 Myopia Management Survey Report” delivers a comprehensive, provider-level view of how pediatric myopia is being managed in the United States today—examining patient volumes, treatment mix, economics, unmet needs, and how clinical behavior is likely to shift as new therapies reach the market. 

Conducted in August and September 2025, the survey captures insights from 150 US-based optometrists and ophthalmologists, including comprehensive and pediatric specialists actively treating myopia. Respondents were drawn from Market Scope’s self-registered provider community and reflect real-world clinical decision-makers with direct experience in myopia control. 

The report provides a structured summary analysis of de-identified survey data, calculated at the respondent level and presented without market extrapolation to clearly show how providers are thinking, prescribing, pricing, and planning. 

The “2025 Single-Use Ophthalmic Surgical Products Market Report” delivers a comprehensive analysis of global and regional markets for disposable ophthalmic surgical products—spotlighting key trends, growth drivers, and strategic opportunities shaping the field. 

The report details market performance and outlook across all major product categories—including viscoelastics, knives, disposable instruments, balanced salt solutions, procedure packs, drapes, sutures, fluid management devices, ocular dyes, capsular tension rings, eye shields, and cautery pencils—and profiles 26 leading companies, highlighting their products, positioning, and future strategies. 

The “2025 Ophthalmic OR Microscopes Market Report” delivers a focused and in-depth analysis of the global market for ophthalmic operating room microscopes. As a specialized supplement to Market Scope’s “2025 Ophthalmic Diagnostic Equipment Market Report,” it offers unmatched insight needed to understand dynamics, evaluate growth opportunities, and benchmark performance within this market. 

The report provides a comprehensive overview of the devices, segmenting the market into basic, standard, and advanced microscope models. For each segment, it presents detailed estimates of unit sales, installed base, and average selling prices, along with profiles of the leading manufacturers shaping the competitive landscape. 

The “2025 Optical Coherence Tomography Market Report” delivers an in-depth, data-driven assessment of the global OCT imaging landscape and the forces reshaping it. The report analyzes clinical, technological, and competitive dynamics across all major OCT segments, providing a clear view of what’s driving adoption today and how the market will evolve over the next five years. 

Market performance is forecast across six distinct product categories—basic OCT, advanced OCT, combination OCT/fundus systems, combination OCT/SLO systems, intraoperative OCT, and OCTA. For each, the report provides estimates of unit sales, installed base trends, and average selling prices. 

The report also profiles 13 leading OCT manufacturers, examining their product portfolios, innovation strategies, competitive positioning, and future outlooks to provide a comprehensive understanding of the companies shaping the future of this market. 

The “2025 Exudative Retinal Disease Pharmaceuticals Market Report” delivers a comprehensive analysis of anti-VEGFs and other therapies for exudative retinal diseases. It highlights key market trends, growth drivers, and future opportunities, with five-year forecasts in units and dollars for branded ocular anti-VEGFs, cancer drugs used off-label, biosimilars, and sustained-drug-delivery devices. The report also breaks down market share by product category and profiles 29 leading competitors, detailing their products, strategies, and market positioning. 

The “2025 Premium Cataract Surgery Market Report” delivers a clear view of the world’s leading PCS markets, covering 13 countries that together generate 84 percent of global PCS manufacturer revenue. From the United States and China to Japan, Germany, and beyond, each market is analyzed in depth, highlighting key trends, growth drivers, and strategic opportunities. 

The report zeroes in on the factors that matter most for companies evaluating market potential or planning to launch premium cataract surgery devices, providing actionable insights to guide investment and expansion decisions.